Through strategic guidance, visionary thinking, and a relentless pursuit of excellence, our senior executives steer SPT Labtech towards achieving its mission of making a real difference to human health through solving advanced laboratory challenges.
Learn more
Board of Directors
Our Board of Directors are committed to driving the long-term success and sustainability of SPT Labtech, providing expert guidance and oversight to execute the company’s ambitious commercial strategy.
Learn more
10
SPT Labtech to collaborate with Illumina to develop automated platform supporting genomics in decentralized healthcare settings
Continue reading
SPT Labtech and BellBrook Labs Introduce High-Throughput Screening Platform for Cancer Research
Continue reading
SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on firefly platform
Continue reading
As part of SPT Labtech’s wider strategic evolution across our core portfolios - including Cryo-EM, liquid handling, and sample management, a decision has been made not to provide any further chameleon instruments. This action allows us to focus on areas where we can have the greatest impact, particularly within Cryo-EM through increased focus on our Quantifoil® grids portfolio offering, as well as continuing to support our broader structural biology offering, including crystallography through our well-established mosquito instruments.
QUANTIFOIL Active grids are unique in being the first commercially produced grids with copper nano-wire covered bars to promote thin film formation through a process of “self-wicking”. This novel grid technology removes the variability of applying an externally applied filter paper to remove excess sample during blotting.